Recurrent VTE in Cancer Still Problematic - MedPage Today

Recurrent VTE in Cancer Still Problematic  MedPage Today

Patients with cancer-associated pulmonary embolism (PE) had a significant risk of recurrent venous thromboembolism (VTE) at 12 months, despite ...



Comments

Popular posts from this blog

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma - Global Banking And Finance Review